Global Needle-free Hypodermic Syringe Market Growth 2026-2032

August 2026 | 111 pages | ID: GF1F599C6F2AEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Needle-free Hypodermic Syringe market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

A needle-free hypodermic syringe, also known as a needle-free injector or needleless syringe, is a medical device that allows the delivery of medications or vaccines into the body without the use of a traditional hypodermic needle.

United States market for Needle-free Hypodermic Syringe is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Needle-free Hypodermic Syringe is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Needle-free Hypodermic Syringe is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Needle-free Hypodermic Syringe players cover Lifecare AS, Antares Pharma, Zoetis, PharmaJet, Aptar Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the “Needle-free Hypodermic Syringe Industry Forecast” looks at past sales and reviews total world Needle-free Hypodermic Syringe sales in 2025, providing a comprehensive analysis by region and market sector of projected Needle-free Hypodermic Syringe sales for 2026 through 2032. With Needle-free Hypodermic Syringe sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Needle-free Hypodermic Syringe industry.

This Insight Report provides a comprehensive analysis of the global Needle-free Hypodermic Syringe landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Needle-free Hypodermic Syringe portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Needle-free Hypodermic Syringe market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Needle-free Hypodermic Syringe and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Needle-free Hypodermic Syringe.

This report presents a comprehensive overview, market shares, and growth opportunities of Needle-free Hypodermic Syringe market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • Electric Needle-Free Injector
  • Hydraulic Needle-Free Injector
Segmentation by Application:
  • Hospital
  • Specialist Clinic
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Lifecare AS
  • Antares Pharma
  • Zoetis
  • PharmaJet
  • Aptar Pharma
  • Portal Instruments
  • Enable Injections
  • Oval Medical Technologies
  • SHL Medical
  • Veloxis Pharmaceuticals
  • Crossject
  • PenJet
Key Questions Addressed in this Report
  • What is the 10-year outlook for the global Needle-free Hypodermic Syringe market?
  • What factors are driving Needle-free Hypodermic Syringe market growth, globally and by region?
  • Which technologies are poised for the fastest growth by market and region?
  • How do Needle-free Hypodermic Syringe market opportunities vary by end market size?
  • How does Needle-free Hypodermic Syringe break out by Type, by Application?
1 SCOPE OF THE REPORT

  1.1 Market Introduction
  1.2 Years Considered
  1.3 Research Objectives
  1.4 Market Research Methodology
  1.5 Research Process and Data Source
  1.6 Economic Indicators
  1.7 Currency Considered
  1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

  2.1 World Market Overview
  2.1.1 Global Needle-free Hypodermic Syringe Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Needle-free Hypodermic Syringe by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Needle-free Hypodermic Syringe by Country/Region, 2021, 2025 & 2032
  2.2 Needle-free Hypodermic Syringe Segment by Type
  2.2.1 Electric Needle-Free Injector
  2.2.2 Hydraulic Needle-Free Injector
  2.2.3 Needle-free Hypodermic Syringe Sales by Type
  2.2.3.1 Global Needle-free Hypodermic Syringe Sales Market Share by Type (2021-2026)
  2.2.3.2 Global Needle-free Hypodermic Syringe Revenue and Market Share by Type (2021-2026)
  2.2.3.3 Global Needle-free Hypodermic Syringe Sale Price by Type (2021-2026)
  2.3 Needle-free Hypodermic Syringe Segment by Application
  2.3.1 Hospital
  2.3.2 Specialist Clinic
  2.3.3 Others
  2.3.4 Needle-free Hypodermic Syringe Sales by Application
  2.3.4.1 Global Needle-free Hypodermic Syringe Sale Market Share by Application (2021-2026)
  2.3.4.2 Global Needle-free Hypodermic Syringe Revenue and Market Share by Application (2021-2026)
  2.3.4.3 Global Needle-free Hypodermic Syringe Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

  3.1 Global Needle-free Hypodermic Syringe Breakdown Data by Company
  3.1.1 Global Needle-free Hypodermic Syringe Annual Sales by Company (2021-2026)
  3.1.2 Global Needle-free Hypodermic Syringe Sales Market Share by Company (2021-2026)
  3.2 Global Needle-free Hypodermic Syringe Annual Revenue by Company (2021-2026)
  3.2.1 Global Needle-free Hypodermic Syringe Revenue by Company (2021-2026)
  3.2.2 Global Needle-free Hypodermic Syringe Revenue Market Share by Company (2021-2026)
  3.3 Global Needle-free Hypodermic Syringe Sale Price by Company
  3.4 Key Manufacturers Needle-free Hypodermic Syringe Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Needle-free Hypodermic Syringe Product Location Distribution
  3.4.2 Players Needle-free Hypodermic Syringe Products Offered
  3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
  3.6 New Products and Potential Entrants
  3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR NEEDLE-FREE HYPODERMIC SYRINGE BY GEOGRAPHIC REGION

  4.1 World Historic Needle-free Hypodermic Syringe Market Size by Geographic Region (2021-2026)
  4.1.1 Global Needle-free Hypodermic Syringe Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Needle-free Hypodermic Syringe Annual Revenue by Geographic Region (2021-2026)
  4.2 World Historic Needle-free Hypodermic Syringe Market Size by Country/Region (2021-2026)
  4.2.1 Global Needle-free Hypodermic Syringe Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Needle-free Hypodermic Syringe Annual Revenue by Country/Region (2021-2026)
  4.3 Americas Needle-free Hypodermic Syringe Sales Growth
  4.4 APAC Needle-free Hypodermic Syringe Sales Growth
  4.5 Europe Needle-free Hypodermic Syringe Sales Growth
  4.6 Middle East & Africa Needle-free Hypodermic Syringe Sales Growth

5 AMERICAS

  5.1 Americas Needle-free Hypodermic Syringe Sales by Country
  5.1.1 Americas Needle-free Hypodermic Syringe Sales by Country (2021-2026)
  5.1.2 Americas Needle-free Hypodermic Syringe Revenue by Country (2021-2026)
  5.2 Americas Needle-free Hypodermic Syringe Sales by Type (2021-2026)
  5.3 Americas Needle-free Hypodermic Syringe Sales by Application (2021-2026)
  5.4 United States
  5.5 Canada
  5.6 Mexico
  5.7 Brazil

6 APAC

  6.1 APAC Needle-free Hypodermic Syringe Sales by Region
  6.1.1 APAC Needle-free Hypodermic Syringe Sales by Region (2021-2026)
  6.1.2 APAC Needle-free Hypodermic Syringe Revenue by Region (2021-2026)
  6.2 APAC Needle-free Hypodermic Syringe Sales by Type (2021-2026)
  6.3 APAC Needle-free Hypodermic Syringe Sales by Application (2021-2026)
  6.4 China
  6.5 Japan
  6.6 South Korea
  6.7 Southeast Asia
  6.8 India
  6.9 Australia
  6.10 China Taiwan

7 EUROPE

  7.1 Europe Needle-free Hypodermic Syringe by Country
  7.1.1 Europe Needle-free Hypodermic Syringe Sales by Country (2021-2026)
  7.1.2 Europe Needle-free Hypodermic Syringe Revenue by Country (2021-2026)
  7.2 Europe Needle-free Hypodermic Syringe Sales by Type (2021-2026)
  7.3 Europe Needle-free Hypodermic Syringe Sales by Application (2021-2026)
  7.4 Germany
  7.5 France
  7.6 UK
  7.7 Italy
  7.8 Russia

8 MIDDLE EAST & AFRICA

  8.1 Middle East & Africa Needle-free Hypodermic Syringe by Country
  8.1.1 Middle East & Africa Needle-free Hypodermic Syringe Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Needle-free Hypodermic Syringe Revenue by Country (2021-2026)
  8.2 Middle East & Africa Needle-free Hypodermic Syringe Sales by Type (2021-2026)
  8.3 Middle East & Africa Needle-free Hypodermic Syringe Sales by Application (2021-2026)
  8.4 Egypt
  8.5 South Africa
  8.6 Israel
  8.7 Turkey
  8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

  9.1 Market Drivers & Growth Opportunities
  9.2 Market Challenges & Risks
  9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

  10.1 Raw Material and Suppliers
  10.2 Manufacturing Cost Structure Analysis of Needle-free Hypodermic Syringe
  10.3 Manufacturing Process Analysis of Needle-free Hypodermic Syringe
  10.4 Industry Chain Structure of Needle-free Hypodermic Syringe

11 MARKETING, DISTRIBUTORS AND CUSTOMER

  11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
  11.2 Needle-free Hypodermic Syringe Distributors
  11.3 Needle-free Hypodermic Syringe Customer

12 WORLD FORECAST REVIEW FOR NEEDLE-FREE HYPODERMIC SYRINGE BY GEOGRAPHIC REGION

  12.1 Global Needle-free Hypodermic Syringe Market Size Forecast by Region
  12.1.1 Global Needle-free Hypodermic Syringe Forecast by Region (2027-2032)
  12.1.2 Global Needle-free Hypodermic Syringe Annual Revenue Forecast by Region (2027-2032)
  12.2 Americas Forecast by Country (2027-2032)
  12.3 APAC Forecast by Region (2027-2032)
  12.4 Europe Forecast by Country (2027-2032)
  12.5 Middle East & Africa Forecast by Country (2027-2032)
  12.6 Global Needle-free Hypodermic Syringe Forecast by Type (2027-2032)
  12.7 Global Needle-free Hypodermic Syringe Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

  13.1 Lifecare AS
  13.1.1 Lifecare AS Company Information
  13.1.2 Lifecare AS Needle-free Hypodermic Syringe Product Portfolios and Specifications
  13.1.3 Lifecare AS Needle-free Hypodermic Syringe Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Lifecare AS Main Business Overview
  13.1.5 Lifecare AS Latest Developments
  13.2 Antares Pharma
  13.2.1 Antares Pharma Company Information
  13.2.2 Antares Pharma Needle-free Hypodermic Syringe Product Portfolios and Specifications
  13.2.3 Antares Pharma Needle-free Hypodermic Syringe Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 Antares Pharma Main Business Overview
  13.2.5 Antares Pharma Latest Developments
  13.3 Zoetis
  13.3.1 Zoetis Company Information
  13.3.2 Zoetis Needle-free Hypodermic Syringe Product Portfolios and Specifications
  13.3.3 Zoetis Needle-free Hypodermic Syringe Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Zoetis Main Business Overview
  13.3.5 Zoetis Latest Developments
  13.4 PharmaJet
  13.4.1 PharmaJet Company Information
  13.4.2 PharmaJet Needle-free Hypodermic Syringe Product Portfolios and Specifications
  13.4.3 PharmaJet Needle-free Hypodermic Syringe Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 PharmaJet Main Business Overview
  13.4.5 PharmaJet Latest Developments
  13.5 Aptar Pharma
  13.5.1 Aptar Pharma Company Information
  13.5.2 Aptar Pharma Needle-free Hypodermic Syringe Product Portfolios and Specifications
  13.5.3 Aptar Pharma Needle-free Hypodermic Syringe Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 Aptar Pharma Main Business Overview
  13.5.5 Aptar Pharma Latest Developments
  13.6 Portal Instruments
  13.6.1 Portal Instruments Company Information
  13.6.2 Portal Instruments Needle-free Hypodermic Syringe Product Portfolios and Specifications
  13.6.3 Portal Instruments Needle-free Hypodermic Syringe Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 Portal Instruments Main Business Overview
  13.6.5 Portal Instruments Latest Developments
  13.7 Enable Injections
  13.7.1 Enable Injections Company Information
  13.7.2 Enable Injections Needle-free Hypodermic Syringe Product Portfolios and Specifications
  13.7.3 Enable Injections Needle-free Hypodermic Syringe Sales, Revenue, Price and Gross Margin (2021-2026)
  13.7.4 Enable Injections Main Business Overview
  13.7.5 Enable Injections Latest Developments
  13.8 Oval Medical Technologies
  13.8.1 Oval Medical Technologies Company Information
  13.8.2 Oval Medical Technologies Needle-free Hypodermic Syringe Product Portfolios and Specifications
  13.8.3 Oval Medical Technologies Needle-free Hypodermic Syringe Sales, Revenue, Price and Gross Margin (2021-2026)
  13.8.4 Oval Medical Technologies Main Business Overview
  13.8.5 Oval Medical Technologies Latest Developments
  13.9 SHL Medical
  13.9.1 SHL Medical Company Information
  13.9.2 SHL Medical Needle-free Hypodermic Syringe Product Portfolios and Specifications
  13.9.3 SHL Medical Needle-free Hypodermic Syringe Sales, Revenue, Price and Gross Margin (2021-2026)
  13.9.4 SHL Medical Main Business Overview
  13.9.5 SHL Medical Latest Developments
  13.10 Veloxis Pharmaceuticals
  13.10.1 Veloxis Pharmaceuticals Company Information
  13.10.2 Veloxis Pharmaceuticals Needle-free Hypodermic Syringe Product Portfolios and Specifications
  13.10.3 Veloxis Pharmaceuticals Needle-free Hypodermic Syringe Sales, Revenue, Price and Gross Margin (2021-2026)
  13.10.4 Veloxis Pharmaceuticals Main Business Overview
  13.10.5 Veloxis Pharmaceuticals Latest Developments
  13.11 Crossject
  13.11.1 Crossject Company Information
  13.11.2 Crossject Needle-free Hypodermic Syringe Product Portfolios and Specifications
  13.11.3 Crossject Needle-free Hypodermic Syringe Sales, Revenue, Price and Gross Margin (2021-2026)
  13.11.4 Crossject Main Business Overview
  13.11.5 Crossject Latest Developments
  13.12 PenJet
  13.12.1 PenJet Company Information
  13.12.2 PenJet Needle-free Hypodermic Syringe Product Portfolios and Specifications
  13.12.3 PenJet Needle-free Hypodermic Syringe Sales, Revenue, Price and Gross Margin (2021-2026)
  13.12.4 PenJet Main Business Overview
  13.12.5 PenJet Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Needle-free Hypodermic Syringe Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Needle-free Hypodermic Syringe Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Electric Needle-Free Injector
Table 4. Major Players of Hydraulic Needle-Free Injector
Table 5. Global Needle-free Hypodermic Syringe Sales by Type (2021-2026) & (K Units)
Table 6. Global Needle-free Hypodermic Syringe Sales Market Share by Type (2021-2026)
Table 7. Global Needle-free Hypodermic Syringe Revenue by Type (2021-2026) & ($ million)
Table 8. Global Needle-free Hypodermic Syringe Revenue Market Share by Type (2021-2026)
Table 9. Global Needle-free Hypodermic Syringe Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Needle-free Hypodermic Syringe Sale by Application (2021-2026) & (K Units)
Table 11. Global Needle-free Hypodermic Syringe Sale Market Share by Application (2021-2026)
Table 12. Global Needle-free Hypodermic Syringe Revenue by Application (2021-2026) & ($ million)
Table 13. Global Needle-free Hypodermic Syringe Revenue Market Share by Application (2021-2026)
Table 14. Global Needle-free Hypodermic Syringe Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Needle-free Hypodermic Syringe Sales by Company (2021-2026) & (K Units)
Table 16. Global Needle-free Hypodermic Syringe Sales Market Share by Company (2021-2026)
Table 17. Global Needle-free Hypodermic Syringe Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Needle-free Hypodermic Syringe Revenue Market Share by Company (2021-2026)
Table 19. Global Needle-free Hypodermic Syringe Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Needle-free Hypodermic Syringe Producing Area Distribution and Sales Area
Table 21. Players Needle-free Hypodermic Syringe Products Offered
Table 22. Needle-free Hypodermic Syringe Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Needle-free Hypodermic Syringe Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Needle-free Hypodermic Syringe Sales Market Share Geographic Region (2021-2026)
Table 27. Global Needle-free Hypodermic Syringe Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Needle-free Hypodermic Syringe Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Needle-free Hypodermic Syringe Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Needle-free Hypodermic Syringe Sales Market Share by Country/Region (2021-2026)
Table 31. Global Needle-free Hypodermic Syringe Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Needle-free Hypodermic Syringe Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Needle-free Hypodermic Syringe Sales by Country (2021-2026) & (K Units)
Table 34. Americas Needle-free Hypodermic Syringe Sales Market Share by Country (2021-2026)
Table 35. Americas Needle-free Hypodermic Syringe Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Needle-free Hypodermic Syringe Sales by Type (2021-2026) & (K Units)
Table 37. Americas Needle-free Hypodermic Syringe Sales by Application (2021-2026) & (K Units)
Table 38. APAC Needle-free Hypodermic Syringe Sales by Region (2021-2026) & (K Units)
Table 39. APAC Needle-free Hypodermic Syringe Sales Market Share by Region (2021-2026)
Table 40. APAC Needle-free Hypodermic Syringe Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Needle-free Hypodermic Syringe Sales by Type (2021-2026) & (K Units)
Table 42. APAC Needle-free Hypodermic Syringe Sales by Application (2021-2026) & (K Units)
Table 43. Europe Needle-free Hypodermic Syringe Sales by Country (2021-2026) & (K Units)
Table 44. Europe Needle-free Hypodermic Syringe Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Needle-free Hypodermic Syringe Sales by Type (2021-2026) & (K Units)
Table 46. Europe Needle-free Hypodermic Syringe Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Needle-free Hypodermic Syringe Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Needle-free Hypodermic Syringe Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Needle-free Hypodermic Syringe Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Needle-free Hypodermic Syringe Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Needle-free Hypodermic Syringe
Table 52. Key Market Challenges & Risks of Needle-free Hypodermic Syringe
Table 53. Key Industry Trends of Needle-free Hypodermic Syringe
Table 54. Needle-free Hypodermic Syringe Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Needle-free Hypodermic Syringe Distributors List
Table 57. Needle-free Hypodermic Syringe Customer List
Table 58. Global Needle-free Hypodermic Syringe Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Needle-free Hypodermic Syringe Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Needle-free Hypodermic Syringe Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Needle-free Hypodermic Syringe Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Needle-free Hypodermic Syringe Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Needle-free Hypodermic Syringe Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Needle-free Hypodermic Syringe Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Needle-free Hypodermic Syringe Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Needle-free Hypodermic Syringe Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Needle-free Hypodermic Syringe Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Needle-free Hypodermic Syringe Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Needle-free Hypodermic Syringe Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Needle-free Hypodermic Syringe Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Needle-free Hypodermic Syringe Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Lifecare AS Basic Information, Needle-free Hypodermic Syringe Manufacturing Base, Sales Area and Its Competitors
Table 73. Lifecare AS Needle-free Hypodermic Syringe Product Portfolios and Specifications
Table 74. Lifecare AS Needle-free Hypodermic Syringe Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Lifecare AS Main Business
Table 76. Lifecare AS Latest Developments
Table 77. Antares Pharma Basic Information, Needle-free Hypodermic Syringe Manufacturing Base, Sales Area and Its Competitors
Table 78. Antares Pharma Needle-free Hypodermic Syringe Product Portfolios and Specifications
Table 79. Antares Pharma Needle-free Hypodermic Syringe Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Antares Pharma Main Business
Table 81. Antares Pharma Latest Developments
Table 82. Zoetis Basic Information, Needle-free Hypodermic Syringe Manufacturing Base, Sales Area and Its Competitors
Table 83. Zoetis Needle-free Hypodermic Syringe Product Portfolios and Specifications
Table 84. Zoetis Needle-free Hypodermic Syringe Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Zoetis Main Business
Table 86. Zoetis Latest Developments
Table 87. PharmaJet Basic Information, Needle-free Hypodermic Syringe Manufacturing Base, Sales Area and Its Competitors
Table 88. PharmaJet Needle-free Hypodermic Syringe Product Portfolios and Specifications
Table 89. PharmaJet Needle-free Hypodermic Syringe Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. PharmaJet Main Business
Table 91. PharmaJet Latest Developments
Table 92. Aptar Pharma Basic Information, Needle-free Hypodermic Syringe Manufacturing Base, Sales Area and Its Competitors
Table 93. Aptar Pharma Needle-free Hypodermic Syringe Product Portfolios and Specifications
Table 94. Aptar Pharma Needle-free Hypodermic Syringe Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Aptar Pharma Main Business
Table 96. Aptar Pharma Latest Developments
Table 97. Portal Instruments Basic Information, Needle-free Hypodermic Syringe Manufacturing Base, Sales Area and Its Competitors
Table 98. Portal Instruments Needle-free Hypodermic Syringe Product Portfolios and Specifications
Table 99. Portal Instruments Needle-free Hypodermic Syringe Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Portal Instruments Main Business
Table 101. Portal Instruments Latest Developments
Table 102. Enable Injections Basic Information, Needle-free Hypodermic Syringe Manufacturing Base, Sales Area and Its Competitors
Table 103. Enable Injections Needle-free Hypodermic Syringe Product Portfolios and Specifications
Table 104. Enable Injections Needle-free Hypodermic Syringe Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Enable Injections Main Business
Table 106. Enable Injections Latest Developments
Table 107. Oval Medical Technologies Basic Information, Needle-free Hypodermic Syringe Manufacturing Base, Sales Area and Its Competitors
Table 108. Oval Medical Technologies Needle-free Hypodermic Syringe Product Portfolios and Specifications
Table 109. Oval Medical Technologies Needle-free Hypodermic Syringe Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Oval Medical Technologies Main Business
Table 111. Oval Medical Technologies Latest Developments
Table 112. SHL Medical Basic Information, Needle-free Hypodermic Syringe Manufacturing Base, Sales Area and Its Competitors
Table 113. SHL Medical Needle-free Hypodermic Syringe Product Portfolios and Specifications
Table 114. SHL Medical Needle-free Hypodermic Syringe Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. SHL Medical Main Business
Table 116. SHL Medical Latest Developments
Table 117. Veloxis Pharmaceuticals Basic Information, Needle-free Hypodermic Syringe Manufacturing Base, Sales Area and Its Competitors
Table 118. Veloxis Pharmaceuticals Needle-free Hypodermic Syringe Product Portfolios and Specifications
Table 119. Veloxis Pharmaceuticals Needle-free Hypodermic Syringe Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Veloxis Pharmaceuticals Main Business
Table 121. Veloxis Pharmaceuticals Latest Developments
Table 122. Crossject Basic Information, Needle-free Hypodermic Syringe Manufacturing Base, Sales Area and Its Competitors
Table 123. Crossject Needle-free Hypodermic Syringe Product Portfolios and Specifications
Table 124. Crossject Needle-free Hypodermic Syringe Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Crossject Main Business
Table 126. Crossject Latest Developments
Table 127. PenJet Basic Information, Needle-free Hypodermic Syringe Manufacturing Base, Sales Area and Its Competitors
Table 128. PenJet Needle-free Hypodermic Syringe Product Portfolios and Specifications
Table 129. PenJet Needle-free Hypodermic Syringe Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. PenJet Main Business
Table 131. PenJet Latest Developments

LIST OF FIGURES

Figure 1. Picture of Needle-free Hypodermic Syringe
Figure 2. Needle-free Hypodermic Syringe Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Needle-free Hypodermic Syringe Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Needle-free Hypodermic Syringe Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Needle-free Hypodermic Syringe Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Needle-free Hypodermic Syringe Sales Market Share by Country/Region (2025)
Figure 10. Needle-free Hypodermic Syringe Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Electric Needle-Free Injector
Figure 12. Product Picture of Hydraulic Needle-Free Injector
Figure 13. Global Needle-free Hypodermic Syringe Sales Market Share by Type in 2026
Figure 14. Global Needle-free Hypodermic Syringe Revenue Market Share by Type (2021-2026)
Figure 15. Needle-free Hypodermic Syringe Consumed in Hospital
Figure 16. Global Needle-free Hypodermic Syringe Market: Hospital (2021-2026) & (K Units)
Figure 17. Needle-free Hypodermic Syringe Consumed in Specialist Clinic
Figure 18. Global Needle-free Hypodermic Syringe Market: Specialist Clinic (2021-2026) & (K Units)
Figure 19. Needle-free Hypodermic Syringe Consumed in Others
Figure 20. Global Needle-free Hypodermic Syringe Market: Others (2021-2026) & (K Units)
Figure 21. Global Needle-free Hypodermic Syringe Sale Market Share by Application (2025)
Figure 22. Global Needle-free Hypodermic Syringe Revenue Market Share by Application in 2026
Figure 23. Needle-free Hypodermic Syringe Sales by Company in 2026 (K Units)
Figure 24. Global Needle-free Hypodermic Syringe Sales Market Share by Company in 2026
Figure 25. Needle-free Hypodermic Syringe Revenue by Company in 2026 ($ millions)
Figure 26. Global Needle-free Hypodermic Syringe Revenue Market Share by Company in 2026
Figure 27. Global Needle-free Hypodermic Syringe Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Needle-free Hypodermic Syringe Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Needle-free Hypodermic Syringe Sales 2021-2026 (K Units)
Figure 30. Americas Needle-free Hypodermic Syringe Revenue 2021-2026 ($ millions)
Figure 31. APAC Needle-free Hypodermic Syringe Sales 2021-2026 (K Units)
Figure 32. APAC Needle-free Hypodermic Syringe Revenue 2021-2026 ($ millions)
Figure 33. Europe Needle-free Hypodermic Syringe Sales 2021-2026 (K Units)
Figure 34. Europe Needle-free Hypodermic Syringe Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Needle-free Hypodermic Syringe Sales 2021-2026 (K Units)
Figure 36. Middle East & Africa Needle-free Hypodermic Syringe Revenue 2021-2026 ($ millions)
Figure 37. Americas Needle-free Hypodermic Syringe Sales Market Share by Country in 2026
Figure 38. Americas Needle-free Hypodermic Syringe Revenue Market Share by Country (2021-2026)
Figure 39. Americas Needle-free Hypodermic Syringe Sales Market Share by Type (2021-2026)
Figure 40. Americas Needle-free Hypodermic Syringe Sales Market Share by Application (2021-2026)
Figure 41. United States Needle-free Hypodermic Syringe Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Needle-free Hypodermic Syringe Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Needle-free Hypodermic Syringe Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Needle-free Hypodermic Syringe Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Needle-free Hypodermic Syringe Sales Market Share by Region in 2026
Figure 46. APAC Needle-free Hypodermic Syringe Revenue Market Share by Region (2021-2026)
Figure 47. APAC Needle-free Hypodermic Syringe Sales Market Share by Type (2021-2026)
Figure 48. APAC Needle-free Hypodermic Syringe Sales Market Share by Application (2021-2026)
Figure 49. China Needle-free Hypodermic Syringe Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Needle-free Hypodermic Syringe Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Needle-free Hypodermic Syringe Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Needle-free Hypodermic Syringe Revenue Growth 2021-2026 ($ millions)
Figure 53. India Needle-free Hypodermic Syringe Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Needle-free Hypodermic Syringe Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Needle-free Hypodermic Syringe Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Needle-free Hypodermic Syringe Sales Market Share by Country in 2026
Figure 57. Europe Needle-free Hypodermic Syringe Revenue Market Share by Country (2021-2026)
Figure 58. Europe Needle-free Hypodermic Syringe Sales Market Share by Type (2021-2026)
Figure 59. Europe Needle-free Hypodermic Syringe Sales Market Share by Application (2021-2026)
Figure 60. Germany Needle-free Hypodermic Syringe Revenue Growth 2021-2026 ($ millions)
Figure 61. France Needle-free Hypodermic Syringe Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Needle-free Hypodermic Syringe Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Needle-free Hypodermic Syringe Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Needle-free Hypodermic Syringe Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Needle-free Hypodermic Syringe Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Needle-free Hypodermic Syringe Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Needle-free Hypodermic Syringe Sales Market Share by Application (2021-2026)
Figure 68. Egypt Needle-free Hypodermic Syringe Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Needle-free Hypodermic Syringe Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Needle-free Hypodermic Syringe Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Needle-free Hypodermic Syringe Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Needle-free Hypodermic Syringe Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Needle-free Hypodermic Syringe in 2026
Figure 74. Manufacturing Process Analysis of Needle-free Hypodermic Syringe
Figure 75. Industry Chain Structure of Needle-free Hypodermic Syringe
Figure 76. Channels of Distribution
Figure 77. Global Needle-free Hypodermic Syringe Sales Market Forecast by Region (2027-2032)
Figure 78. Global Needle-free Hypodermic Syringe Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Needle-free Hypodermic Syringe Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Needle-free Hypodermic Syringe Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Needle-free Hypodermic Syringe Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Needle-free Hypodermic Syringe Revenue Market Share Forecast by Application (2027-2032)


More Publications